Date | Name | Shares | Transaction | Value |
Apr 9, 2025
| Celeste Beeks Mastin President and CEO; Director |
16,229
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.75 per share |
856,079.75
|
Apr 9, 2025
| Celeste Beeks Mastin President and CEO; Director |
17,540
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $52.75 per share |
925,235.00
|
Apr 9, 2025
| Celeste Beeks Mastin President and CEO; Director |
17,204
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $52.75 per share |
907,511.00
|
Apr 9, 2025
| Celeste Beeks Mastin President and CEO; Director |
16,119
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $52.75 per share |
850,277.25
|
Apr 9, 2025
| Celeste Beeks Mastin President and CEO; Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Apr 9, 2025
| Srilata A. Zaheer Director |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Apr 9, 2025
| Srilata A. Zaheer Director |
1,346
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $52.75 per share |
71,001.50
|
Apr 1, 2025
| Heather A. Campe Sr. VP, International Growth |
4,453
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Apr 1, 2025
| John J. Corkrean Executive VP and CFO |
24,425
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Feb 5, 2025
| Nathanial D. Weaver Exec VP, Business Transform. |
5,803
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Feb 5, 2025
| Nathanial D. Weaver Exec VP, Business Transform. |
6,970
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $63.13 per share |
440,016.10
|
Feb 5, 2025
| Nathanial D. Weaver Exec VP, Business Transform. |
7,058
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $63.13 per share |
445,571.54
|
Jan 30, 2025
| Robert Joseph Martsching VP, Corporate Controller |
806
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Jan 30, 2025
| Robert Joseph Martsching VP, Corporate Controller |
4,606
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Jan 30, 2025
| Zhiwei Cai Executive Vice President, EA |
1,299
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Jan 30, 2025
| Du Xinyu Sr. VP, Global R&D |
1,344
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Jan 30, 2025
| Muhammad Shahbaz Malik Senior VP, BAS |
1,792
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Jan 30, 2025
| Muhammad Shahbaz Malik Senior VP, BAS |
10,237
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Jan 30, 2025
| Heather A. Campe Sr. VP, International Growth |
1,896
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Jan 30, 2025
| Zhiwei Cai Executive Vice President, EA |
7,422
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|